These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9034372

  • 1. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
    Biernat W, Kleihues P, Yonekawa Y, Ohgaki H.
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
    [Abstract] [Full Text] [Related]

  • 2. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
    Das A, Tan WL, Teo J, Smith DR.
    J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
    Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1997 Oct; 94(4):303-9. PubMed ID: 9341929
    [Abstract] [Full Text] [Related]

  • 6. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A, Watanabe K, Plate KH, Yonekawa Y, Kleihues P, Ohgaki H.
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [Abstract] [Full Text] [Related]

  • 7. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 8. Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.
    Schiebe M, Ohneseit P, Hoffmann W, Meyermann R, Rodemann HP, Bamberg M.
    J Neurooncol; 2000 Sep; 49(3):197-203. PubMed ID: 11212898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [Abstract] [Full Text] [Related]

  • 11. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS, Lee MC, Kang SS, Kim JH, Jung S, Kim YJ, Lee JH, Ahn KY, Lee JS, Cheon JY.
    J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas.
    Rieske P, Kordek R, Bartkowiak J, Debiec-Rychter M, Biernat W, Liberski PP.
    Pol J Pathol; 1998 Aug; 49(3):145-9. PubMed ID: 9810172
    [Abstract] [Full Text] [Related]

  • 13. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H.
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [Abstract] [Full Text] [Related]

  • 14. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
    Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD.
    Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP.
    Cancer Res; 2000 Jan 15; 60(2):417-24. PubMed ID: 10667596
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of glioma cell lines for amplification and overexpression of MDM2.
    He J, Reifenberger G, Liu L, Collins VP, James CD.
    Genes Chromosomes Cancer; 1994 Oct 15; 11(2):91-6. PubMed ID: 7529554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.